Document Detail

Efficacy of infliximab in a patient with refractory idiopathic retroperitoneal fibrosis.
MedLine Citation:
PMID:  23021007     Owner:  NLM     Status:  Publisher    
Glucocorticoids are the mainstay of treatment of idiopathic retroperitoneal fibrosis (IRF). However, relapses are frequent upon tapering of the glucocorticoid dose. A variety of traditional immunosuppressants have been proposed as steroid-sparing agents, but some patients fail to adequately respond to combined glucocorticoid and immunosuppressive therapy. We report a patient with IRF refractory to combined glucocorticoid and methotrexate therapy treated with the anti-TNF-α monoclonal antibody infliximab. Infliximab was administered at 5 mg/kg/bodyweight at week 0, 2, 6 and 8-weekly thereafter for 3 consecutive years. Drug efficacy and safety were assessed clinically and by laboratory tests at treatment onset and subsequently before each infusion. In addition, 18FFluorodeoxyglucose (FDG) positron emission computerised tomography (PET/CT) and abdominal CT scans were used to monitor disease activity and response to treatment. Infliximab therapy resulted in a satisfactory clinical and laboratory response paralleled by an improvement in imaging findings. No serious adverse events were noted. Infliximab may be an effective and safe treatment for refractory IRF. A controlled study is required to confirm our findings.
Maria Grazia Catanoso; Lucia Spaggiari; Luca Magnani; Nicolò Pipitone; Annibale Versari; Luigi Boiardi; Giulia Pazzola; Pierpaolo Pattacini; Carlo Salvarani
Related Documents :
23074637 - Effectiveness of two-year versus one-year use of dual antiplatelet therapy in reducing ...
24231597 - Continuous passive motion following cartilage surgery: does a common protocol exist?
25006277 - Importance of early and deeper responses to long-term survival in cml patients: implica...
20464717 - Graft type for femoro-popliteal bypass surgery.
21438837 - Interpersonal variability and present diagnostic dilemmas in bosniak classification sys...
22136827 - Elevated parathyroid hormone predicts mortality in dialysis patients undergoing valve s...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-9-27
Journal Detail:
Title:  Clinical and experimental rheumatology     Volume:  -     ISSN:  0392-856X     ISO Abbreviation:  Clin. Exp. Rheumatol.     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-10-1     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8308521     Medline TA:  Clin Exp Rheumatol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Rheumatology Unit, Azienda Ospedaliera ASMN, IRCCS, Reggio Emilia, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Novel insight into qualitative standardization of Polygoni avicularis herba (Ph. Eur.).
Next Document:  Low rates of hepatotoxicity among Asian patients with paracetamol overdose: a review of 1024 cases.